2/1
12:32 am
alny
Alnylam Pharmaceuticals (ALNY) Valuation Check After Recent Share Price Weakness [Yahoo! Finance]
Low
Report
Alnylam Pharmaceuticals (ALNY) Valuation Check After Recent Share Price Weakness [Yahoo! Finance]
1/31
07:03 pm
alny
Analyst Views Diverge as Alnylam Pharmaceuticals, Inc. (ALNY) Targets $5.1B Revenue and Long-Term Growth [Yahoo! Finance]
Low
Report
Analyst Views Diverge as Alnylam Pharmaceuticals, Inc. (ALNY) Targets $5.1B Revenue and Long-Term Growth [Yahoo! Finance]
1/30
12:26 pm
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Morgan Stanley from $495.00 to $408.00. They now have an "equal weight" rating on the stock.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Morgan Stanley from $495.00 to $408.00. They now have an "equal weight" rating on the stock.
1/30
08:03 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at HC Wainwright from $570.00 to $510.00. They now have a "buy" rating on the stock.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at HC Wainwright from $570.00 to $510.00. They now have a "buy" rating on the stock.
1/30
08:03 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Bank of America Corporation from $529.00 to $462.00. They now have a "buy" rating on the stock.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Bank of America Corporation from $529.00 to $462.00. They now have a "buy" rating on the stock.
1/29
08:00 am
alny
Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2025 Financial Results
Low
Report
Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2025 Financial Results
1/28
08:03 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $527.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $527.00 price target on the stock.
1/28
05:12 am
alny
Should You Buy Alnylam Pharmaceuticals Before Feb. 12? [Yahoo! Finance]
Low
Report
Should You Buy Alnylam Pharmaceuticals Before Feb. 12? [Yahoo! Finance]
1/27
08:57 am
alny
Wells Fargo Raises Alnylam (ALNY) Revenue Estimates for Amvuttra Despite Projected Margin Compression [Yahoo! Finance]
Low
Report
Wells Fargo Raises Alnylam (ALNY) Revenue Estimates for Amvuttra Despite Projected Margin Compression [Yahoo! Finance]
1/20
11:01 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Royal Bank Of Canada from $500.00 to $465.00. They now have an "outperform" rating on the stock.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Royal Bank Of Canada from $500.00 to $465.00. They now have an "outperform" rating on the stock.
1/20
10:52 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Wells Fargo & Company from $479.00 to $376.00. They now have an "equal weight" rating on the stock.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Wells Fargo & Company from $479.00 to $376.00. They now have an "equal weight" rating on the stock.
1/16
04:54 pm
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) was upgraded by analysts at
Weiss Ratings from a "sell (d-)" rating to a "hold (c-)" rating.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) was upgraded by analysts at
Weiss Ratings from a "sell (d-)" rating to a "hold (c-)" rating.
1/14
07:11 pm
alny
JPM26: 2025 a “breakout year” for rare disease biotechs [Yahoo! Finance]
Low
Report
JPM26: 2025 a “breakout year” for rare disease biotechs [Yahoo! Finance]
1/13
06:42 pm
alny
Alnylam Pharmaceuticals (ALNY) Is Down 9.0% After Ambitious 2026 Guidance And 2030 Plan Reveal [Yahoo! Finance]
Low
Report
Alnylam Pharmaceuticals (ALNY) Is Down 9.0% After Ambitious 2026 Guidance And 2030 Plan Reveal [Yahoo! Finance]
1/12
03:51 pm
alny
Adimab Reports Strong Partnering Year for 2025 [Yahoo! Finance]
Low
Report
Adimab Reports Strong Partnering Year for 2025 [Yahoo! Finance]
1/12
02:47 pm
alny
Alnylam Pharmaceuticals Unveils “Alnylam 2030” as Amvuttra Drives Breakout Growth at JPMorgan Conf. [Yahoo! Finance]
Low
Report
Alnylam Pharmaceuticals Unveils “Alnylam 2030” as Amvuttra Drives Breakout Growth at JPMorgan Conf. [Yahoo! Finance]
1/12
10:37 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Bank of America Corporation from $530.00 to $529.00. They now have a "buy" rating on the stock.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Bank of America Corporation from $530.00 to $529.00. They now have a "buy" rating on the stock.
1/12
08:04 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target raised by analysts at Needham & Company LLC from $520.00 to $529.00. They now have a "buy" rating on the stock.
Medium
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target raised by analysts at Needham & Company LLC from $520.00 to $529.00. They now have a "buy" rating on the stock.
1/12
07:17 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
1/11
05:13 pm
alny
Alnylam Launches "Alnylam 2030" Strategy to Drive Next Era of Growth and Patient Impact [Yahoo! Finance]
Medium
Report
Alnylam Launches "Alnylam 2030" Strategy to Drive Next Era of Growth and Patient Impact [Yahoo! Finance]
1/11
05:00 pm
alny
Alnylam Launches “Alnylam 2030” Strategy to Drive Next Era of Growth and Patient Impact
Medium
Report
Alnylam Launches “Alnylam 2030” Strategy to Drive Next Era of Growth and Patient Impact
1/11
09:22 am
alny
Is Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) 19% ROE Better Than Average? [Yahoo! Finance]
Medium
Report
Is Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) 19% ROE Better Than Average? [Yahoo! Finance]
1/8
12:50 pm
alny
Fidelity Puritan Fund Q3 2025 Commentary [Seeking Alpha]
Low
Report
Fidelity Puritan Fund Q3 2025 Commentary [Seeking Alpha]
1/8
12:20 pm
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Truist Financial Corporation from $535.00 to $530.00. They now have a "buy" rating on the stock.
Medium
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Truist Financial Corporation from $535.00 to $530.00. They now have a "buy" rating on the stock.
1/7
07:12 pm
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) Seems To Use Debt Quite Sensibly [Yahoo! Finance]
Medium
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) Seems To Use Debt Quite Sensibly [Yahoo! Finance]